ZURA peer analysis
Zura Bio (ZURA) against its competitors: price, today's move, 1-year return and market value side by side.
ZURA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AARD Aardvark Therapeutics | $1.16 | 4.50% | -89.43% | – |
| ARCT Arcturus | $10.30 | 10.04% | 8.33% | $308.96M |
| ASMB Assembly Biosciences | $20.42 | 2.10% | -37.71% | $404.57M |
| ENTA Enanta Pharmaceuticals | $11.00 | 9.13% | -7.69% | $310.19M |
| FHTX Foghorn Therapeutics | $1.87 | -1.84% | -52.37% | – |
| IMRX Immuneering | $3.61 | 7.12% | -47.43% | – |
| NAUT Nautilus Biotechnology | $2.25 | 4.65% | 42.38% | – |
| PYXS Pyxis Oncology | $1.71 | 6.46% | -58.82% | – |
| SGMT Sagimet Biosciences | $9.86 | 8.11% | 17.37% | – |
| TNYA Tenaya Therapeutics | $0.36 | 13.61% | -77.10% | – |
| ZURA Zura Bio | $4.07 | 9.41% | 2.48% | – |
- ZURA's peers: AARD (Aardvark Therapeutics), ARCT (Arcturus), ASMB (Assembly Biosciences), ENTA (Enanta Pharmaceuticals), FHTX (Foghorn Therapeutics), IMRX (Immuneering), NAUT (Nautilus Biotechnology), PYXS (Pyxis Oncology).
Updated 2026-11-07 11:54 UTC